| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |